The Aethlon Medical mission is to create innovative devices that address unmet medical needs in cancer, infectious disease, and other life threatening conditions. The Aethlon ADAPT system is an expansive technology platform that converges affinity drug agents and plasma membrane technology to create therapeutic filtration devices that selectively target the removal of harmful particles from the entire circulatory system. Our lead therapeutic candidate is the Aethlon Hemopurifier, a device with broad spectrum capabilities against viral pathogens and immunosuppressive cancer exosomes. In human studies, Hemopurifier therapy has provided significant viral load reductions in HIV and hepatitis C virus infected individuals without the administration of antiviral drugs. We are now focused on advancing our Hemopurifier as an adjunct strategy to improve the benefit of established infectious disease and cancer treatment regimens. Based on studies conducted by government and non government research organizations, the Hemopurifier is also a leading broad spectrum treatment candidate to address bioterror and pandemic threats.
Quote | Aethlon Medical Inc. (NASDAQ:AEMD)
Last: | $1.68 |
---|---|
Change Percent: | -1.75% |
Open: | $1.74 |
Close: | $1.68 |
High: | $1.74 |
Low: | $1.67 |
Volume: | 14,918 |
Last Trade Date Time: | 03/28/2024 03:00:00 am |
News | Aethlon Medical Inc. (NASDAQ:AEMD)
2024-03-22 17:22:52 ET More on Aethlon Medical Seeking Alpha’s Quant Rating on Aethlon Medical Historical earnings data for Aethlon Medical Financial information for Aethlon Medical Read the full article on Seeking Alpha For further details see...
2024-02-21 09:30:00 ET SAN DIEGO - February 21, 2024 (Investorideas.com Newswire) Aethlon Medical, Inc. ( Nasdaq: AEMD ), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, today announced that it entered into a Materia...
Message Board Posts | Aethlon Medical Inc. (NASDAQ:AEMD)
Subject | By | Source | When |
---|---|---|---|
$AEMD Aethlon Medical Inc | mick | investorshub | 04/30/2023 11:11:18 PM |
Choo choo play as they want the chase. $AEMD mb | Mt. Blanc | investorshub | 04/21/2023 12:14:19 PM |
I can't find any major news today on | twogreen2c | investorshub | 04/20/2023 2:22:53 PM |
IMO : ONE WORD | power11 | investorshub | 04/20/2023 2:20:13 PM |
$AEMD Aethlon Medical Inc | mick | investorshub | 04/15/2023 3:19:13 PM |
News, Short Squeeze, Breakout and More Instantly...
Aethlon Medical Will Perform Pre-Clinical Studies to Explore Potential Synergies With its First-in-Class Hemopurifier® Blood Filtration System...
2024-02-21 09:30:00 ET SAN DIEGO - February 21, 2024 (Investorideas.com Newswire) Aethlon Medical, Inc. ( Nasdaq: AEMD ), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, today announced that it entered into a Materia...
Aethlon Medical Enters Into Materials Transfer Agreement for Santersus AG's NucleoCapture and HemoNucleoCapture Devices PR Newswire Aethlon Medical Will Perform Pre-Clinical Studies to Explore Potential Synergies With its First-in-Class Hemopurifier ® Blood Filtration...